Suministro de medicamentos exclusivos con principios activos belimumab, mepolizumab, niraparib y momelotinib del laboratorio glaxosmithkline, s.a
- Buyer
- Servicio Murciano de Salud - Junta de Compras
- Published
- 2026-11-11
- Deadline
- Not provided
- Sources
- TED
- Value
- Not provided
Description
The description is in the source language.
Suministro de medicamentos exclusivos con principios activos belimumab, mepolizumab, niraparib y momelotinib del laboratorio Glaxosmithkline, s.a
CPV: 33652000, 33652100, 33652300, 33673000
Membership
Read notice previews free of charge. Official notice and document links, construction permits and personal MCP access require an active paid membership.
Read